Retraction Note to: Akt2-Dependent Phosphorylation of Radixin in Regulation of Mrp-2 Trafficking in WIF-B Cells (Digestive Diseases and Sciences, (2016), 61, 2, (453-463), 10.1007/s10620-015-3905-4);Akt2-Dependent Phosphorylation of Radixin in Regulation of Mrp-2 Trafficking in WIF-B Cells

Digestive Diseases and Sciences

Volumn 61, Issue 2, 2016, Pages 453-463

  Suda, Jo ^a   Rockey, Don C ^b   Karvar, Serhan ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Bile canaliculus; Bile transporter; Cytoskeleton; Liver; PI3K; Protein kinase B

Indexed keywords

AKT1 PROTEIN; INSULIN; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 2; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE B BETA; RADIXIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; AKT1 PROTEIN, HUMAN; AKT2 PROTEIN, HUMAN; CYTOSKELETON PROTEIN; GLUTATHIONE; MEMBRANE PROTEIN; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2;

APICAL MEMBRANE; ARTICLE; CELL LYSATE; CELL MIGRATION; CELL STIMULATION; CELLULAR DISTRIBUTION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOSOL; CYTOSOLIC FRACTION; FLUORESCENCE MICROSCOPY; GENETIC TRANSFECTION; IMMUNOBLOTTING; IMMUNOFLUORESCENCE MICROSCOPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; ANALOGS AND DERIVATIVES; CELL LINE; GENE SILENCING; GENETICS; HUMAN; LIVER CELL; METABOLISM; MUTATION; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN TRANSPORT;

CELL LINE; CYTOSKELETAL PROTEINS; GENE KNOCKDOWN TECHNIQUES; GLUTATHIONE; HEPATOCYTES; HUMANS; MEMBRANE PROTEINS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; MUTATION; PHOSPHORYLATION; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-AKT;

EID: 84973442857     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-021-07350-2     Document Type: Erratum

References (33)

1. Kojima H, Sakurai S, Uemura M, et al. Disturbed colocalization of multidrug resistance protein 2 and radixin in human cholestatic liver diseases. J Gastroenterol Hepatol. 2008;23:e120–e128.
2. Karvar S, Suda J, Zhu L, et al. Distribution dynamics and functional importance of NHERF1 in regulation of Mrp-2 trafficking in hepatocytes. Am J Physiol Cell Physiol. 2014;307:C727–C737.
3. Kojima H, Sakurai S, Yoshiji H, et al. The role of radixin in altered localization of canalicular conjugate export pump Mrp2 in cholestatic rat liver. Hepatol Res. 2008;38:202–210.
4. Suda J, Rockey DC, Karvar S. Phosphorylation dynamics of radixin in hypoxia-induced hepatocyte injury. Am J Physiol Gastrointest Liver Physiol. 2015;308:G313–G324.
5. Suda J, Zhu L, Karvar S. Phosphorylation of radixin regulates cell polarity and Mrp-2 distribution in hepatocytes. Am J Physiol Cell Physiol. 2011;300:C416–C424.
6. Wang W, Soroka CJ, Mennone A, et al. Radixin is required to maintain apical canalicular membrane structure and function in rat hepatocytes. Gastroenterology. 2006;131:878–884.
7. Bretscher A, Edwards K, Fehon RG. ERM proteins and merlin: integrators at the cell cortex. Nat Rev Mol Cell Biol. 2002;3:586–599.
8. Hoeflich KP, Ikura M. Radixin: cytoskeletal adopter and signaling protein. Int J Biochem Cell Biol. 2004;36:2131–2136.
9. Fehon RG, McClatchey AI, Bretscher A. Organizing the cell cortex: the role of ERM proteins. Nat Rev Mol Cell Biol. 2010;11:276–287.
10. Matsui T, Maeda M, Doi Y, et al. Rho-kinase phosphorylates COOH-terminal threonines of ezrin/radixin/moesin (ERM) proteins and regulates their head-to-tail association. J Cell Biol. 1998;140:647–657.
11. Campbell AM, Zhang ZY. Phosphatase of regenerating liver: a novel target for cancer therapy. Exp Opin Ther Targets. 2014;18:555–569.
12. Jump DB. Fatty acid regulation of hepatic lipid metabolism. Curr Opin Clin Nutr Metab Care. 2011;14:115–120.
13. Matsuda S, Kobayashi M, Kitagishi Y. Roles for PI3K/AKT/PTEN pathway in cell signaling of nonalcoholic fatty liver disease. ISRN Endocrinol. 2013;2013:427432.
14. Risso G, Blaustein M, Pozzi B, et al. Akt/PKB: one kinase, many modifications. Biochem J. 2015;468:203–214.
15. Schultze SM, Jensen J, Hemmings BA, et al. Promiscuous affairs of PKB/AKT isoforms in metabolism. Arch Physiol Biochem. 2011;117:70–77.
16. Pal I, Mandal M. PI3K and Akt as molecular targets for cancer therapy: current clinical outcomes. Acta Pharmacol Sin. 2012;33:1441–1458.
17. Boaglio AC, Zucchetti AE, Sanchez Pozzi EJ, et al. Phosphoinositide 3-kinase/protein kinase B signaling pathway is involved in estradiol 17beta-d-glucuronide-induced cholestasis: complementarity with classical protein kinase C. Hepatology. 2010;52:1465–1476.
18. Hermann C, Assmus B, Urbich C, et al. Insulin-mediated stimulation of protein kinase Akt: a potent survival signaling cascade for endothelial cells. Arterioscler Thromb Vasc Biol. 2000;20:402–409.
19. Kim YB, Peroni OD, Franke TF, et al. Divergent regulation of Akt1 and Akt2 isoforms in insulin target tissues of obese Zucker rats. Diabetes. 2000;49:847–856.
20. Ihrke G, Neufeld EB, Meads T, et al. WIF-B cells: an in vitro model for studies of hepatocyte polarity. J Cell Biol. 1993;123:1761–1775.
21. Mitsuuchi Y, Johnson SW, Moonblatt S, et al. Translocation and activation of AKT2 in response to stimulation by insulin. J Cell Biochem. 1998;70:433–441.
22. Sumitani S, Goya K, Testa JR, et al. Akt1 and Akt2 differently regulate muscle creatine kinase and myogenin gene transcription in insulin-induced differentiation of C2C12 myoblasts. Endocrinology. 2002;143:820–828.
23. Hebert M, Potin S, Sebbagh M, et al. Rho-ROCK-dependent ezrin-radixin-moesin phosphorylation regulates Fas-mediated apoptosis in Jurkat cells. J Immunol. 2008;181:5963–5973.
24. Ng T, Parsons M, Hughes WE, et al. Ezrin is a downstream effector of trafficking PKC-integrin complexes involved in the control of cell motility. EMBO J. 2001;20:2723–2741.
25. Baumgartner M, Sillman AL, Blackwood EM, et al. The Nck-interacting kinase phosphorylates ERM proteins for formation of lamellipodium by growth factors. Proc Natl Acad Sci USA. 2006;103:13391–13396.
26. Belkina NV, Liu Y, Hao JJ, et al. LOK is a major ERM kinase in resting lymphocytes and regulates cytoskeletal rearrangement through ERM phosphorylation. Proc Natl Acad Sci USA. 2009;106:4707–4712.
27. Viswanatha R, Ohouo PY, Smolka MB, et al. Local phosphocycling mediated by LOK/SLK restricts ezrin function to the apical aspect of epithelial cells. J Cell Biol. 2012;199:969–984.
28. Lu M, Wan M, Leavens KF, et al. Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1. Nat Med. 2012;18:388–395.
29. He L, Hou X, Kanel G, et al. The critical role of AKT2 in hepatic steatosis induced by PTEN loss. Am J Pathol. 2010;176:2302–2308.
30. Li C, Li Y, He L, et al. PI3K/AKT signaling regulates bioenergetics in immortalized hepatocytes. Free Radic Biol Med. 2013;60:29–40.
31. Galicia VA, He L, Dang H, et al. Expansion of hepatic tumor progenitor cells in Pten-null mice requires liver injury and is reversed by loss of AKT2. Gastroenterology. 2010;139:2170–2182.
32. Li X, Leu S, Cheong A, et al. Akt2, phosphatidylinositol 3-kinase, and PTEN are in lipid rafts of intestinal cells: role in absorption and differentiation. Gastroenterology. 2004;126:122–135.
33. Lee-Kwon W, Johns DC, Cha B, et al. Constitutively active phosphatidylinositol 3-kinase and AKT are sufficient to stimulate the epithelial Na+/H+ exchanger 3. J Biol Chem. 2001;276:31296–31304.